Dr. Fiona Kerr

Research Fellow

Fiona Kerr
Postal address:
Glasgow Caledonian University
70 Cowcaddens Road
Glasgow
United Kingdom

Research interests

Biography

  • Research Fellow, Glasgow Caledonian University, 2017-present
  • Lecturer in Biomedical Sciences, Edinburgh Napier University, 2016-2017
  • Postdoctoral Research Associate (Alzheimer’s Research UK), Institute of Healthy Ageing,  University College London, 2009-2017
  • Postdoctoral Research Associate (EU-FP7, AddNeuroMed Project), Institute of Healthy Ageing, University College London, 2006-2009
  • PhD (Lloyds Charities Trust/Alzheimer’s Research Trust PhD Scholarship), Kings College London, 2002-2006
  • Research Technician (Eisai London Research Laboratories), 2000-2002
  • BSc Pharmacology (Hons with Work Placement at AstraZeneca) University of Glasgow, 2000

 

Research overview

Alzheimer’s disease (AD) is the leading cause of dementia in humans, affecting families across all communities. As our population grows older this poses a significant challenge for future generations, since current therapies do not slow-down the progression of memory loss in dementia patients. A priority area for AD research is therefore to develop new drugs to halt the disease, by finding ways to protect neurons as pathology progresses.

 

My current interest is in understanding the molecular mechanisms by which the ageing process increases neuronal vulnerability to AD pathology, using Drosophila and human induced pluripotent stem cell (hiPSC) neuron models of disease. By targeting ageing, a common risk factor for many neurodegenerative diseases, my work aims to deliver potential new targets for the development of therapies to maintain neuronal integrity in AD and, potentially, other neurological conditions. 

View graph of relations

  1. Published

    Reduced insulin signaling maintains electrical transmission in a neural circuit in aging flies

    Augustin, H., McGourty, K., Allen, M. J., Madem, S. K., Adcot, J., Kerr, F., Wong, C. T., Vincent, A., Godenschwege, T., Boucrot, E. & Partridge, L. 13 Sep 2017 In : PLoS Biology. 15, 9, p. e2001655

    Research output: Contribution to journalArticle

  2. Published

    Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer’s disease

    Kerr, F., Sofola-Adesakin, O., Ivanov, D. K., Gatliff, J., Perez-Nievas, B. G., Bertrand, H. C., Martinez, P., Callard, R., Snoeren, I., Cocheme, H. M., Adcott, J., Khericha, M., Castillo-Quan, J. I., Wells, G., Noble, W., Thornton, J. & Partridge, L. 2 Mar 2017 In : PLoS Genetics. 13, 3

    Research output: Contribution to journalArticle

  3. Published

    Molecular mechanisms of lithium action: switching the light on multiple targets for dementia using animal models

    Kerr, F., Bjedov, I. & Sofola-Adesakin, O. 28 Aug 2018 In : Frontiers in Molecular Neuroscience. 11

    Research output: Contribution to journalArticle

View all »

  1. Carnegie Trust Research Assessor

    Activity: External academic engagementMembership of peer review panel or committee

  2. ARUK Scotland Network Board Member

    Activity: External academic engagementMembership of peer review panel or committee

  3. Scientific Reports

    Activity: Editorial work or peer review of publicationsPublication peer-review

View all »